Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation

Atherosclerosis. 2012 Jan;220(1):215-8. doi: 10.1016/j.atherosclerosis.2011.09.035. Epub 2011 Oct 14.

Abstract

Objective: Endogenous thrombin generation (ETP) may be critically involved in obesity associated thromboembolism.

Methods: Three hundred and one participants of the STyrian Juvenile OBesity (STYJOBS)/Early DEteCTion of Atherosclerosis (EDECTA) study cohort (age, 16-58years) were analysed. ETP was measured by the new CE-IVD marked Siemens-Innovance(®) ETP test on a BCS-XP analyser, and correlated to clinical findings and extended lipometry-based anthropometric data, biomarkers, and coagulation parameters.

Results: In the overweight/obese study group, ETP and fibrinogen levels were significantly higher compared to controls (p<0.001). In a multiple stepwise regression including all subjects, subcutaneous adipose tissue thickness of upper back, cholesterol and ultrasensitive C-reactive protein were the best predictors for ETP.

Conclusion: Trunk weighted obesity together with low grade inflammation and hypercholesterolemia enhance thrombin generation.

Trial registration: ClinicalTrials.gov NCT00482924.

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Austria
  • Biomarkers / blood
  • Blood Coagulation*
  • Body Mass Index
  • C-Reactive Protein / analysis
  • Case-Control Studies
  • Cholesterol / blood*
  • Female
  • Fibrinogen / analysis
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / complications*
  • Inflammation / blood
  • Inflammation / complications*
  • Inflammation Mediators / blood
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / complications*
  • Obesity / pathology
  • Prospective Studies
  • Regression Analysis
  • Risk Assessment
  • Risk Factors
  • Subcutaneous Fat / pathology
  • Thrombin / analysis*
  • Thromboembolism / blood
  • Thromboembolism / etiology*
  • Young Adult

Substances

  • Biomarkers
  • Inflammation Mediators
  • Fibrinogen
  • C-Reactive Protein
  • Cholesterol
  • Thrombin

Associated data

  • ClinicalTrials.gov/NCT00482924